Company / Book Value per Share
Perspective Therapeutics, Inc. Book Value per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.385
FY2022
5-year range
$0.075 / $0.385
FY2018-FY2022
Trend
+245.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed +245% YoY in FY2022, a notable deviation from the 9-year average annual change of +51%.
Based on SEC 10-K filings.
$0.385 in FY2022 with a 5-year CAGR of +0.4%.
Improved from $0.075 to $0.385 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +26.9%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2022, book value per share increased 245.4% year-over-year.
- Peak book value per share was recorded in FY2016.
- Lowest book value per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.385 | +245.4% |
| FY2021 | $0.111 | +49.3% |
| FY2020 | $0.075 | -60.3% |
| FY2019 | $0.188 | -36.9% |
| FY2018 | $0.298 | -21.1% |
| FY2017 | $0.378 | -34.5% |
| FY2016 | $0.577 | +346.4% |
| FY2015 | $0.129 | -23.1% |
| FY2014 | $0.168 | -10.6% |
| FY2013 | $0.188 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026